[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@PavanPav17997](/creator/twitter/PavanPav17997)
"Final Verdict: Cipla Q1 FY26: Revenue mild miss profit beat. Indias record Q1 keeps momentum solid. NA soft but pipeline & first biosimilar keep confidence high. Focus shifts to GLP-1 & gAdvair ramp from FY2627 #Cipla #Q1FY26 #Q1Results #Nifty50 #StocksInFocus Dis - Not Reco"  
![@PavanPav17997 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1808282427875643392.png) [@PavanPav17997](/creator/x/PavanPav17997) on [X](/post/tweet/1948885715850584344) 2025-07-25 23:18:57 UTC XX followers, XXX engagements


"🏦 Balance Sheet: Total Debt: XXX Cr ( from XXX Cr YoY). Cash: 10838 Cr ( from 8996 Cr YoY). Net Cash: 10379 Cr rock solid. Inventory: 6091 Cr (+10% YoY). Receivables: 6254 Cr (+25% YoY) #StockMarketUpdate #stockmarketcrash"  
![@PavanPav17997 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1808282427875643392.png) [@PavanPav17997](/creator/x/PavanPav17997) on [X](/post/tweet/1948885706052689928) 2025-07-25 23:18:55 UTC XX followers, XX engagements


"🧵 Kotak Mahindra Bank Q1FY26 Earnings Deep Dive PAT: 3282 Cr 🔻7% YoY 🔻9% QoQ (Est: 3497 Cr ❌ Miss) NII: 7259 Cr 🔺6% YoY 🔻3.3% QoQ (Est: 7391 Cr ❌ Miss) Other Income: 3081 Cr 🔻5% YoY (Est: 3172 Cr ❌ Miss) GNPA: XXXX% vs XXXX% QoQ ❌ Miss"  
![@PavanPav17997 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1808282427875643392.png) [@PavanPav17997](/creator/x/PavanPav17997) on [X](/post/tweet/1949522742719520861) 2025-07-27 17:30:16 UTC XX followers, XXX engagements


"4 📉 Credit Quality Snapshot GNPA: XXXX% (vs XXXX% QoQ) NNPA: XXXX% (flat QoQ) PCR: XX% (vs 78%) Slippages: 1812 Cr (22% QoQ) Write-offs: XXX Cr ⚠ Pain in MFI CV rural book (seasonal) visible"  
![@PavanPav17997 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1808282427875643392.png) [@PavanPav17997](/creator/x/PavanPav17997) on [X](/post/tweet/1949522750101471310) 2025-07-27 17:30:18 UTC XX followers, XX engagements


"5/ 🔐 The product mix continues its strategic shift. ULIP now contributes XX% while non-par savings is XX% annuities make up XX% and protection is 6%. Par sits at 5%. SBI Life is de-risking from pure ULIP dependence"  
![@PavanPav17997 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1808282427875643392.png) [@PavanPav17997](/creator/x/PavanPav17997) on [X](/post/tweet/1948345263091044612) 2025-07-24 11:31:23 UTC XX followers, XX engagements


"Key Financial Metrics Net Interest Margin (NIM) at XXXX% vs XXXX% YoY Return on Assets (ROA) fell to XXXX% from XXXX% YoY Return on Equity (ROE) down to XXXXX% from XXXXX% YoY Cost-to-income ratio improved to XXXX% from XXXX% Cost of funds jumped to XXXX% from 4.61%"  
![@PavanPav17997 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1808282427875643392.png) [@PavanPav17997](/creator/x/PavanPav17997) on [X](/post/tweet/1949522745483522241) 2025-07-27 17:30:17 UTC XX followers, XX engagements


"2 Core Metrics Speak Loud 💰Revenue (): 3334 Cr ➕ +21.8% YoY 💵Revenue ($): $389.7M ➕ +18.8% YoY 📈EBIT: XXX Cr ➕ +34.8% YoY 🏦 PAT: XXX Cr ➕ +38.7% YoY 💹EPS: XXXX ➕ +36.5% YoY Margins stable despite INR appreciation & rising amortization 📉 #StockMarketIndia"  
![@PavanPav17997 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1808282427875643392.png) [@PavanPav17997](/creator/x/PavanPav17997) on [X](/post/tweet/1948000021196271803) 2025-07-23 12:39:31 UTC XX followers, XX engagements


"REC Q1 FY26 Results Electrifying Growth 1/ Profit Soars XX% YoY 🟢 PAT: 4451 Cr 🔼 +29% YoY from 3442 Cr 🔼 +16.4% QoQ from 3824 Cr (Q4 FY25) Highest-ever quarterly profit driven by growth in disbursements stable margins and improved recoveries. #Q1Results"  
![@PavanPav17997 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1808282427875643392.png) [@PavanPav17997](/creator/x/PavanPav17997) on [X](/post/tweet/1948604186268238258) 2025-07-25 04:40:15 UTC XX followers, XX engagements


"Rev: 1932 Cr (7.4% YoY) softness due to base effect & price pressure. Albuterol: #1 rank in US MDI inhaler mkt (19.5% share). Launched Nano Paclitaxel (ANDA) & Nilotinib (NDA). Signed 1st US biosimilar launch gAdvair nearing gSymbicort in FY27 #stockmarketcrash"  
![@PavanPav17997 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1808282427875643392.png) [@PavanPav17997](/creator/x/PavanPav17997) on [X](/post/tweet/1948885702038749319) 2025-07-25 23:18:54 UTC XX followers, XX engagements


"5 📈 Loan Book Segment Growth (YoY) Home Loans + LAP: 🔺19% SME: 🔺23% PL + Consumer: 🔺20% Business Banking: 🔺18% Tractor Loans: 🔺17% Credit Cards: 🔻12% Microcredit: 🔻43% 🧠 Focus shifting to secured & high-quality lending"  
![@PavanPav17997 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1808282427875643392.png) [@PavanPav17997](/creator/x/PavanPav17997) on [X](/post/tweet/1949522757319905694) 2025-07-27 17:30:20 UTC XX followers, X engagements